Xtalks Webinars (@xtalks) 's Twitter Profile
Xtalks Webinars

@xtalks

Provides insight on Life Science issues (#Pharma, #Biotech, #MedicalDevice) via breaking news & interactive webinars with industry experts

ID: 136013508

linkhttp://www.xtalks.com calendar_today22-04-2010 20:12:26

17,17K Tweet

26,26K Takipçi

15,15K Takip Edilen

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

In this episode, Ayesha chats with Dr. Sumita Bhatta, VP and Global Development Therapeutic Head of Rare Disease at Amgen, about how big pharma is approaching rare disease innovation and patient centricity in today’s drug development landscape. Listen now at

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

To mark World AIDS Vaccine Day 2025 on Sunday, May 18, explore the latest clinical trial updates, delivery innovations and affordability models — along with real-world barriers to HIV treatment access — at buff.ly/R4Gpqat by Soumya Shashikumar.

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

❓ How is AI revolutionizing clinical trials? Join IQVIA’s webinar to explore AI’s role in enhancing strategy planning, site selection, and monitoring. Register now: buff.ly/oo1bTZ8 #AIinHealthcare #ClinicalTrials #IQVIA

❓ How is AI revolutionizing clinical trials? Join IQVIA’s webinar to explore AI’s role in enhancing strategy planning, site selection, and monitoring. Register now: buff.ly/oo1bTZ8 
#AIinHealthcare #ClinicalTrials #IQVIA
Xtalks Webinars (@xtalks) 's Twitter Profile Photo

Abeona’s Zevaskyn has received FDA approval for the rare skin disease RDEB, becoming the first and only cell-based gene therapy approved for the condition. Read more at buff.ly/2fzvhbP by Ayesha Rashid about the treatment, which is described as a cell sheet-based gene

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

The FDA just expanded unannounced inspections to foreign facilities. Our latest article breaks down why, what’s changing and how this may impact quality control abroad. Learn more at buff.ly/wWIALBu by Soumya Shashikumar.

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

Learn how digital tools can streamline clinical study operations and make trials more participant-friendly, with insights from Studypages’ Koen De Lombaert, MD. MBA, and Eron Villarreal. Watch the Spotlight video and read more at buff.ly/YHIhhdR by Vera Kovacevic.

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

US president Donald Trump signed an executive order last week to encourage drug manufacturing in the US. It includes specific directives for the FDA and EPA to prioritize reviews, approvals and permits for drug manufacturing facilities. Read more at buff.ly/eIRHiqQ by

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

❓ How is AI shaping the future of biologics production? Join Asimov’s webinar to explore how AI enhances cell line development and bioprocess design. Register now: buff.ly/O9hSWBr #AIinBiotech #Biomanufacturing #Webinar

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

Discover how OncoC4 and its founder Dr. Yang Liu are redefining cancer treatment through precision immunotherapies that target the tumor microenvironment and novel immune checkpoints. Read more in our Xtalks Clinical Edge™ feature at buff.ly/fkfkEkf by Vera Kovacevic.

Discover how OncoC4 and its founder Dr. Yang Liu are redefining cancer treatment through precision immunotherapies that target the tumor microenvironment and novel immune checkpoints. Read more in our Xtalks Clinical Edge™ feature at buff.ly/fkfkEkf by <a href="/VeraKovacevic3/">Vera Kovacevic</a>.
Xtalks Webinars (@xtalks) 's Twitter Profile Photo

The EU is investing €500 million (roughly $537 million) into scientific research in Europe through its new “Choose Europe for Science” campaign. Read more at buff.ly/FeQJABR by Ayesha Rashid about the program, which aims to attract and support top researchers from around

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

Amid Trump’s tariff threats on drug imports, big pharma is doubling down on its US presence, with BMS announcing an investment of $40B over 5 years and Gilead committing $11B in fresh US investments. Read more at buff.ly/Upw8JxT by Ayesha Rashid.

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

Dive into our latest Spotlight with Scout’s Amy Franco, where we examine how dedicated patient liaisons coordinate travel, reimbursements and accessibility — making it easier for patients to stay enrolled in clinical trials. Watch the video and read more at

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

Teal Health’s Teal Wand has received FDA approval as the first at-home self-collection device for cervical cancer screening in the US. Read more at buff.ly/45ZjQ1h by Ayesha Rashid about the tool, which offers a convenient alternative to traditional in-clinic Pap smears.

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

The FDA just approved three new natural food colorings — including algae-derived blue and mineral-based white. Read how these pigments could shape clean-label strategies at buff.ly/F1Il2jt by Soumya Shashikumar.

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

Precision psychiatry is reshaping neuropsychiatric clinical trials. Alto Neuroscience’s Dr. Amit Etkin discusses how harnessing biomarkers, EEG and wearables to tailor therapies can cut placebo noise and boost success. Read more in our Xtalks Clinical Edge™ feature at

Precision psychiatry is reshaping neuropsychiatric clinical trials. Alto Neuroscience’s Dr. Amit Etkin discusses how harnessing biomarkers, EEG and wearables to tailor therapies can cut placebo noise and boost success. Read more in our Xtalks Clinical Edge™ feature at
Xtalks Webinars (@xtalks) 's Twitter Profile Photo

❓ How can digital technologies improve Alzheimer’s trials? Join Medidata’s webinar to learn how DCAs and eCOA solutions enhance data quality and patient experience. Register now: buff.ly/tcMCy35 #Alzheimers #eCOA #DigitalHealth #Webinar

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

❓ How can HPAPIs transform drug development? Join Aragen’s webinar to learn how these potent molecules improve treatments with fewer side effects. Register now: buff.ly/bltuIfw #HPAPIs #DrugDevelopment #Webinar

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

Read our Xtalks Clinical Edge™ feature with DiMe’s Sarah Valentine to explore how digital endpoints — from wearable sensors to smartphone data — can reshape clinical trial design, accelerate drug development and bring patient-centric insights to the forefront. Read more at

Read our Xtalks Clinical Edge™ feature with DiMe’s Sarah Valentine to explore how digital endpoints — from wearable sensors to smartphone data — can reshape clinical trial design, accelerate drug development and bring patient-centric insights to the forefront. Read more at
Xtalks Webinars (@xtalks) 's Twitter Profile Photo

❓ How can food manufacturers stay ahead of food labeling challenges and avoid costly errors? Join Schlafender Hase’s webinar with Marc Chaillou and Peter Muller to explore the common pitfalls in food labeling, how to improve compliance and insights from the pharmaceutical

Xtalks Webinars (@xtalks) 's Twitter Profile Photo

US president Trump’s 2026 budget plan proposes major cuts to healthcare and social programs, while boosting defense and border security spending. Read more at buff.ly/vAuEbAH by Ayesha Rashid about the proposed budget, which includes billion-dollar funding cuts to health